United Therapeutics' 2024 Report Showcases Commitment to Patients

United Therapeutics Reveals Its 2024 Corporate Responsibility Report

United Therapeutics Corporation (Nasdaq: UTHR), a renowned public benefit corporation, has taken a significant step by releasing its 2024 Corporate Responsibility and Public Benefit Report. This report illustrates the company's journey throughout the previous fiscal year and highlights their ongoing commitment to develop innovative solutions for their patients.

Progress Toward Patient-Centric Goals

At the core of United Therapeutics' mission is the dedication to ensuring that no patient is left behind. The report details their substantial achievements in the past year, primarily driven by their pioneering organ manufacturing initiatives. Christopher Causey, Chair of the Nominating and Governance Committee, expressed enthusiasm about the company's growth trajectory, particularly emphasizing the vital correlation between patient health and the health of our ecosystems. United Therapeutics strives to meet their aims while pursuing innovative construction practices, including their goal of net zero energy for new buildings.

Impact on Patient Care

In 2023, United Therapeutics positively impacted over 14,500 patients, illustrating their robust service offerings. Among these, more than a hundred patients benefited from their centralized ex vivo lung perfusion (EVLP) service, showcasing the company’s dedication to enhancing transplant accessibility. Their patient assistance program has facilitated access to treatments for more than 32,000 individuals since its inception, further showcasing the company’s commitment to patient welfare.

Employee and Environmental Commitment

The commitment extends internally as well; over 90% of United Therapeutics employees have consistently stated their pride in working for a company recognized as a great place to work. This reflects a supportive workplace culture that aligns with the company's goals. On the sustainability front, approximately 26% of United Therapeutics' properties are LEED certified, including their innovative warehouse designed to adhere to green building standards.

Advancements in Sustainability

United Therapeutics invests significantly in renewable energy, including maintaining a 7-MW capacity onsite solar field, demonstrating their responsibility toward environmental stewardship. James Edgemond, CFO of the company, reiterated that understanding the interconnectedness across various challenges allows United Therapeutics to navigate their goals effectively while balancing resources for optimal outcomes.

New Corporate Responsibility Website

In conjunction with this report, United Therapeutics has unveiled an updated corporate responsibility website. This new portal features additional sections tailored to stakeholder interests, including useful resources and compelling impact stories from employees, further revealing the innovative spirit at United Therapeutics.

The Vision of United Therapeutics

United Therapeutics operates under a unique principle as the first publicly traded biotech firm structured as a public benefit corporation. Their purpose centers on providing a brighter future for patients through the development of novel pharmaceutical therapies and technology aimed at increasing transplantable organ availability. This mission highlights their unwavering commitment to patient well-being and community health.

Frequently Asked Questions

What is United Therapeutics' main goal?

United Therapeutics aims to provide innovative pharmaceutical therapies and technology to enhance the availability of transplantable organs, ensuring no patient is left behind.

How many patients does United Therapeutics serve?

The company reported serving over 14,500 patients in 2023, demonstrating significant growth in their service offerings.

What sustainability efforts is United Therapeutics undertaking?

United Therapeutics has committed to energy-efficient practices, such as achieving LEED gold certification for their buildings and investing in onsite solar fields.

How does United Therapeutics support its employees?

With over 90% of employees stating that United Therapeutics is a great place to work, the company emphasizes a supportive and engaging workplace culture.

Where can I find additional resources about United Therapeutics?

For further information, check their updated corporate responsibility website, featuring valuable resources and impact stories illustrating their efforts.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.